A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2011
11/30/2011	CN102264370A 投与眼的flap抑制剂的局部调配物 Topical formulations administered eye flap inhibitors
11/30/2011	CN102260252A 可用于治疗细菌感染的新噁唑烷酮 New oxazolidinone useful for treating bacterial infections
11/30/2011	CN102258771A 重组水蛭素在防治糖尿病性白内障中的应用 Application of recombinant hirudin in the prevention and treatment of diabetic cataract
11/30/2011	CN102258721A 一种五谷养生中药及其制法 One kind of grain health medicine Jiqizhifa
11/30/2011	CN102258718A 一种配制酒及其制备方法和用途 One kind of wine preparation and its preparation method and use
11/30/2011	CN102258709A 一种治疗糖尿病视网膜病变的中药制剂及其制备方法 A treatment for diabetic retinopathy medicine and its preparation method
11/30/2011	CN102258692A 一种石斛夜光丸及其制备方法 One kind of Dendrobium luminous balls and its preparation method
11/30/2011	CN102258681A 一种治疗漏睛疮的中药 A treatment for sore eyes leak medicine
11/30/2011	CN102258518A 石杉碱甲在制备治疗青光眼和/或缺血诱发的视神经损伤的药物中的用途 Huperzine A in the preparation of the treatment of glaucoma and / or ischemia-induced damage of the optic nerve in the use of drugs
11/30/2011	CN102258509A 大黄酸或大黄酸类化合物与精氨酸的复合物在制备治疗糖尿病并发症药物中的应用 Rhubarb rhubarb acid or acids and arginine compound used in the preparation of a medicament for the treatment of diabetic complications
11/30/2011	CN102258499A 叶黄素微囊的制备方法 Lutein prepared microcapsules
11/30/2011	CN102258461A 选择性诱导晶状体上皮细胞脱落和/或死亡以阻止后囊膜混浊的处理溶液和方法 Selective induction of lens epithelial cell loss and / or death to deal with solutions and methods to prevent capsular opacification after
11/30/2011	CN102258460A 黄芩素脂质体凝胶及其制备方法 Scutellarein liposomal gel and its preparation method
11/30/2011	CN102258457A Non-aqueous composition
11/30/2011	CN101926890B 一种治疗干眼症的药物 A treatment for dry eye drug
11/30/2011	CN101575365B 一种抗病毒蛋白及其制备方法和应用 An anti-viral protein and its preparation method and application
11/30/2011	CN101549021B 杠板归药材的检测方法 Perfoliatum detection herbs
11/30/2011	CN101537019B 一种治疗中耳炎的药物 A method of treating otitis media drug
11/30/2011	CN101305777B 银杏果肉酱 Ginkgo fruit sauce
11/30/2011	CN101296706B Il-23和il-17拮抗剂治疗自身免疫性眼部炎性疾病的用途 Il-23 and il-17 antagonist in the treatment of autoimmune ocular inflammatory disease use of
11/30/2011	CN101163486B 阿奇霉素在生产用于治疗眼部感染的药物中的用途 Azithromycin use in the manufacture of a medicament for the treatment of eye infections in
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067406 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
11/29/2011	US8067039 Extract of plant Dendrobii caulis and preparing process thereof
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2479711C Formulation
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/24/2011	WO2011146863A1 Surgical compositions containing sigma-receptor agonists
11/24/2011	WO2011145062A1 Treatment of tinnitus and related auditory dysfunctions
11/24/2011	WO2011085155A3 Formulations and methods for dissolving cerumen
11/24/2011	WO2011053768A3 System and method for stabilizing corneal tissue after treatment
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288170 Retinal derivatives and methods for the use thereof for the treatment of visual disorders
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288157 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288155 Sirna compounds and methods of use thereof
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288106 Adenine receptor ligands
11/24/2011	US20110288101 Surgical compositions containing sigma-receptor agonists
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288087 Fused ring compound and use thereof
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288062 Biodegradable polymer system
11/24/2011	US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis
11/24/2011	US20110288056 Once daily formulations of tetracyclines
11/24/2011	US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287103 Sustained-release formulations of topiramate
11/24/2011	US20110287088 Modulation of olfml-3 mediated angiogenesis
11/24/2011	US20110287079 Supporting material for cell sheet
11/24/2011	US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011	US20110287035 Method and composition for hyperthermally treating cells
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110287028 Methods of Treatment Using Human Anti-IL-23 Antibodies
11/24/2011	US20110287026 Sirt4 and uses thereof
11/24/2011	US20110287024 Vascular endothelial cell growth factor antagonists
11/24/2011	US20110286932 Optical method for the detection of alzheimer's disease
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP2046287B1 Methods and compositions for the treatment and prevention of infections
11/23/2011	EP1927353B1 Remedy for corneal diseases
11/23/2011	CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions
11/23/2011	CN102250914A Protein for treating ocular vascular proliferation
11/23/2011	CN102250253A Fusogenic peptide containing thrombin fragment
11/23/2011	CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide
11/23/2011	CN102247542A Medicine for treating diabetes and kidney disease, cataract and other diabetic complications
11/23/2011	CN102247477A Method for preparing bezoar soft capsules for clearing away heat and reducing fire as well as dispelling wind and relieving pain
11/23/2011	CN102247394A Medical application of Harpagoside ingredient
11/23/2011	CN102247378A Application of pristimerin in preparing anti-angiogenic medicine
11/23/2011	CN102018789B Traditional Chinese medicine composition for alleviating asthenopia and preparation method thereof
11/23/2011	CN102008596B Chinese medicine eye compressing bag for treating myopic eye
11/23/2011	CN101766668B Burdock extract and preparation method and application thereof
11/23/2011	CN101700285B Application of rumex japonicus in preparing medicines
11/23/2011	CN101336720B Nutrient powder capable of enhancing eyesight
11/23/2011	CN101293034B Medicament composition for treating otitis medium and preparation thereof
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063054 Method of treatment of retinal ischemia with diazoxide
11/22/2011	US8063033 Therapeutic beta-lactams
11/22/2011	US8063031 Implants and methods for treating inflammation-mediated conditions of the eye
11/22/2011	US8063013 Method of treating glaucoma comprising administering a composition comprising human BMP7
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011	CA2486917C Topically applicable pharmaceutical preparation containing roflumilast
11/22/2011	CA2480452C Thioxanthine derivatives as myeloperoxidase inhibitors
11/22/2011	CA2471974C Quinazolinone derivatives and their use as cb agonists
11/22/2011	CA2456025C An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
11/22/2011	CA2444278C Modified cyclosporine which can be used as a pro-drug and use thereof
11/22/2011	CA2416808C Derivatives of branched-chain lipophilic molecules and uses thereof
11/17/2011	WO2011143559A2 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
11/17/2011	WO2011142381A1 Benzo- or pyrido-imidazole derivative
11/17/2011	WO2011113855A3 Pharmaceutical composition for treatment of increased intraocular pressure
11/17/2011	WO2011085209A3 Methods and compositions for applying moxifloxacin to the ear
11/17/2011	WO2011081383A3 Composition including naphthoquinone compound for treating and preventing hearing loss
11/17/2011	WO2011071970A3 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/17/2011	WO2011071916A3 Sr-bi as a predictor of human female infertility and responsiveness to treatment
11/17/2011	WO2011063161A3 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 531